The number of patients now waiting for more than 18 weeks for an elective operation has shot up 80 percent in just a year, according to a report by the Patients Association.
News
Dementia atlas shows care inequalities across England
Huge differences in the quality of care of patients with dementia have been revealed by the government’s new Dementia Atlas.
Second breakthrough badge for Janssen’s antidepressive
Janssen’s esketamine has picked up a breakthrough therapy designation in the US as a treatment for major depressive disorder with imminent risk for suicide, potentially speeding up development and review timelines.
ViiV kicks off Ph III trials of two-drug HIV regimen
ViiV Healthcare has kicked off a Phase III programme that it hopes will lead to regulatory filings for a two-drug regimen of Tivicay and Epivir as a treatment for HIV in adults who have not received prior antiretroviral therapy.
Roche signs deal with Eleven Bio
Roche has bagged access to Eleven Biotherapeutics’ eye disease candidate EBI-031 in a deal worth around $270 million.
CR UK launches bladder cancer drug trial
Cancer Research UK has launched a new clinical trial of a drug that researchers are hoping could prevent bladder cancers from becoming resistant to chemotherapy.
BMS to supply Opdivo for Bavarian Nordic trial
Bristol-Myers Squibb has agreed to supply Bavarian Nordic with Opdivo for use in a clinical trial assessing the immunotherapy in combination with experimental drug CV301.
UCB bags key US patent win
UCB has secured an important win for the protection of its anti-epileptic Vimpat in the US this week after the Delaware District Court confirmed the validity of a key patent for the drug.
NHS paediatric workforce ‘at breaking point’
Doctors are warning that UK paediatric care is at breaking point because of growing staff shortages across the country.
HealthUnlocked, Doctify team up for new digital health service
Two London startups are planning to launch a new digital service that offers online forums and direct access to experts for pregnancy and skin conditions.
Endo withdraws abuse-deterrent labelling for Opana ER
Dublin, Ireland-based speciality pharma Endo International is withdrawing its US application to add abuse deterrent labelling to its long-acting opioid Opana ER.
BMA seeks nod for more junior doctors’ strikes
Junior doctors in England are gearing up for another round of strikes in protest over government’s planned imposition of a new working contract, after refusing to accept its terms.
NHS patients missing out on cancer drugs
Thousands of NHS patients in the UK are missing out on access to innovative treatments that are available to patients living in some other countries of comparable wealth, finds new research by charities Breast Cancer Now and Prostate Cancer UK.
Charity finds high stress levels among primary care workers
Almost nine in ten (88 percent) primary care workers find their work life stressful, which is significantly higher than the wider UK workforce (56 percent), research undertaken by UK charity MIND has found.
NICE looks to expand Brilique reach
Thousands of patients are set to benefit from AstraZeneca’s clot buster Brilique after cost regulators endorsed its longer term use on the NHS to prevent cardiovascular events.
